CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 30 enrolled
Drug / intervention
Promethazine +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02136420
NCT02136420Phase 4Completed
CompareCT.gov

Countermeasures to Reduce Sensorimotor Impairment and Space Motion Sickness Resulting From Altered Gravity Levels

Faisal_Karmali@MEEI.HARVARD.EDU·interventional·Posted May 13, 2014·Updated Jan 8, 2018

In Brief

A Phase 4 clinical trial evaluating Promethazine, Hyper gravity training, and 2 other interventions for Vestibular. Completed, enrolled 30 participants across 1 site.

Detailed Summary

The investigators will study adaptation of motion perception and manual control in altered gravity, including the effects of a drug (promethazine). The investigators will also study whether promethazine affects motion perceptual thresholds.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVestibular
CountriesUnited States
CollaboratorsNational Space Biomedical Research Institute, Massachusetts Institute of Technology

Timeline

Phase 4CompletedFinished
201520162017201820192020202120222023202420252026
First PostedMay 13, 2014
Enrollment StartJun 1, 2014
Primary CompletionDec 1, 2016
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 12.1 years ago

Interventions

Promethazinedrug

Subject receives promethazine

Hyper gravity trainingbehavioral

Subject receives hypergravity training before testing

Placebodrug

Placebo

No hypergravity trainingbehavioral

Subjects do not receive normal Earth gravity